[VRDN] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
05-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 21.83%
YoY- -155.61%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 256 216 214 208 1,090 1,451 54 183.01%
PBT -29,491 -25,693 -28,946 -14,043 -17,964 -18,460 -90,742 -52.82%
Tax 227 -196 3 91 9 55 130 45.15%
NP -29,491 -25,497 -28,946 -14,043 -17,964 -18,460 -90,742 -52.82%
Tax Rate - - - - - - - -
Total Cost 29,747 25,713 29,160 14,251 19,054 19,911 90,796 -52.57%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -11,519.92 -11,804.17 -13,526.17 -6,751.44 -1,648.07 -1,272.23 -168,040.74 -83.33%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -1.06 -0.98 -2.59 -1.26 -2.22 -2.91 -23.07 -87.24%
EPS Diluted -1.06 -0.98 -2.59 -1.26 -2.22 -2.91 -23.07 -87.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.